GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » 6-1 Month Momentum %

BioPharma Credit (LSE:BPCR) 6-1 Month Momentum % : 2.81% (As of May. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-27), BioPharma Credit's 6-1 Month Momentum % is 2.81%.

The industry rank for BioPharma Credit's 6-1 Month Momentum % or its related term are showing as below:

LSE:BPCR's 6-1 Month Momentum % is ranked worse than
56.34% of 1743 companies
in the Asset Management industry
Industry Median: 4.07 vs LSE:BPCR: 2.81

Competitive Comparison of BioPharma Credit's 6-1 Month Momentum %

For the Asset Management subindustry, BioPharma Credit's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPharma Credit's 6-1 Month Momentum % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's 6-1 Month Momentum % falls into.



BioPharma Credit  (LSE:BPCR) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioPharma Credit  (LSE:BPCR) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


BioPharma Credit 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPharma Credit (LSE:BPCR) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines